Clinical Trial Update: Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of microtransplantation for refractory or relapsed hematologic malignancies in younger patients was terminated, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 2 | Status: TERMINATED | Results posted: 2017-11-01